CRESCENT BIOPHARMA, INC.
Recent Filings
All 625 filings →| Form | Description | Date |
|---|---|---|
| 424B3 | 424B3 | Mar 17, 2026 |
| POS AM | POS AM | Mar 3, 2026 |
| EFFECT | — | Mar 3, 2026 |
| S-8 | S-8 | Feb 26, 2026 |
| 424B3 | 424B3 | Feb 26, 2026 |
| 8-K | 8-K | Feb 26, 2026 |
| 10-K | 10-K | Feb 26, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 17, 2026 |
| SCHEDULE 13G/A | — | Feb 5, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Date |
|---|---|---|---|---|
| Pinkas Jan | Chief Scientific Officer | Award / Grant | 17,507 | Dec 15, 2025 |
| Doughty Christopher Grant | Chief Business Officer | Award / Grant | 8,000 | Dec 15, 2025 |
| Brumm Joshua T | Chief Executive Officer | Award / Grant | 10,000 | Dec 15, 2025 |
| Scalzo Richard William | Chief Financial Officer | Award / Grant | 5,000 | Dec 15, 2025 |
| McNeill Jonathan | President and COO | Award / Grant | 6,000 | Dec 15, 2025 |
| Im Ellie Eunkyung | Chief Medical Officer | Award / Grant | 16,298 | Dec 15, 2025 |
| Lynch Ryan | See Remarks | Award / Grant | 4,000 | Dec 15, 2025 |
| Bispham Barbara Harlin | See Remarks | Award / Grant | 12,422 | Dec 15, 2025 |
| Harwin Peter Evan | — | Purchase | 1,360,000 @ $13.41 | Dec 4, 2025 |
| Siren, L.L.C. | — | Sale | 260,873 @ $0.19 | Aug 7, 2024 |